Treatment of severe traumatic brain injury in German pediatric intensive care units-a survey of current practice.


Journal

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 02 2019
accepted: 18 02 2019
pubmed: 4 3 2019
medline: 31 7 2020
entrez: 4 3 2019
Statut: ppublish

Résumé

German pediatric guidelines for severe traumatic brain injury (TBI) management expired in 2011. Thus, divergent evidence-based institutional protocols are predominantly being followed. We performed a survey of current Pediatric Intensive Care Unit (PICU) management of isolated severe TBI in Germany to reveal potential varying practices. Seventy German PICUs were invited to join an anonymous online survey from February to May 2017. Twenty-nine participants (41.4%) successfully completed the survey (17 university hospitals and 12 district hospitals). The majority of items were polar (yes/no) or scaled (e.g., never - always). Main topics were imaging, neurosurgery, neuromonitoring, adjuvant therapy, and medication. Severity of TBI was defined via Glasgow Coma Scale. The majority of respondents (93.1%) had internal TBI standards, and patients were mainly administered to interdisciplinary trauma units. The use of advanced neuromonitoring techniques, intracranial hypertension management, and drug treatment differed between PICUs. Routine administration of hypertonic saline in TBI-associated cerebral edema was performed by 3.4%, while it was never an option for 31.0% of the participants. Prophylactic anticonvulsive therapy was restrictively performed. If indicated, the main anticonvulsive drugs used were phenobarbital and levetiracetam. Neuroendocrine follow-up was recommended/performed by 58.6% of the PICUs. This survey provides an overview of the current PICU practices of isolated severe TBI management in Germany and demonstrates a wide instrumental and therapeutical range, revealing an unmet need for the revised national guideline and further (international) clinical trials for the treatment of severe TBI in pediatrics.

Identifiants

pubmed: 30826957
doi: 10.1007/s00381-019-04098-z
pii: 10.1007/s00381-019-04098-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

815-822

Références

Pediatr Crit Care Med. 2016 Jul;17(7):649-57
pubmed: 27243415
J Neurosurg. 2012 Sep;117(3):589-96
pubmed: 22794321
J Pediatr Surg. 2006 Mar;41(3):505-13
pubmed: 16516625
Anesthesiol Clin. 2009 Jun;27(2):213-40
pubmed: 19703674
Pediatr Crit Care Med. 2013 Mar;14(3):239-47
pubmed: 23392360
NeuroRehabilitation. 2012;30(3):219-23
pubmed: 22635127
MMWR Surveill Summ. 2011 May 6;60(5):1-32
pubmed: 21544045
Am J Health Syst Pharm. 2013 May 1;70(9):759-66
pubmed: 23592358
J Head Trauma Rehabil. 2005 Jan-Feb;20(1):95-109
pubmed: 15668573
JAMA Pediatr. 2013 Aug 1;167(8):700-7
pubmed: 23754213
J Neurosurg. 2006 Oct;105(4 Suppl):281-6
pubmed: 17328278
Childs Nerv Syst. 2015 Dec;31(12):2257-68
pubmed: 26337700
Surg Clin North Am. 2017 Oct;97(5):1015-1030
pubmed: 28958355
Crit Care Med. 2014 Oct;42(10):2258-66
pubmed: 25083982
J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1452-61
pubmed: 11185666
J Pediatr Surg. 2006 Jan;41(1):83-7; discussion 83-7
pubmed: 16410113
Acta Neurochir (Wien). 2005 Mar;147(3):231-42; discussion 242
pubmed: 15627922
Pediatr Crit Care Med. 2012 Jan;13 Suppl 1:S1-82
pubmed: 22217782
Lancet. 2004 Oct 9-15;364(9442):1321-8
pubmed: 15474134
Neurocrit Care. 2010 Apr;12(2):165-72
pubmed: 19898966
J Neurosurg Pediatr. 2014 Feb;13(2):209-15
pubmed: 24286154
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Surg Neurol Int. 2015 Nov 23;6:177
pubmed: 26673517
Neurocrit Care. 2018 Jun;28(3):302-313
pubmed: 29476389
Childs Nerv Syst. 2017 Oct;33(10):1663-1667
pubmed: 29149394
Ann Am Thorac Soc. 2016 Sep;13(9):1527-37
pubmed: 27268952
J Head Trauma Rehabil. 2008 Nov-Dec;23(6):394-400
pubmed: 19033832
Klin Padiatr. 2013 Jan;225(1):34-40
pubmed: 23203384
Ann Plast Surg. 2016 Jan;76(1):3-5
pubmed: 26418779
Lancet Neurol. 2013 Jun;12(6):546-53
pubmed: 23664370
J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):753-9
pubmed: 18559460
Lancet Public Health. 2016 Dec;1(2):e76-e83
pubmed: 29253420
Pediatr Neurosurg. 2003 Jul;39(1):27-31
pubmed: 12784075
Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):878-88
pubmed: 23812605
J Crit Care. 2013 Oct;28(5):883.e9-13
pubmed: 23566730

Auteurs

A P Regensburger (AP)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Loschgestr. 15, 91054, Erlangen, Germany. adrian.regensburger@uk-erlangen.de.

V Konrad (V)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Loschgestr. 15, 91054, Erlangen, Germany.

R Trollmann (R)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Loschgestr. 15, 91054, Erlangen, Germany.

I Y Eyüpoglu (IY)

Department of Neurosurgery, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

H Huebner (H)

Institute for Women's Healthcare (IFG), Erlangen, Germany; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.

J Zierk (J)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Loschgestr. 15, 91054, Erlangen, Germany.

T M K Völkl (TMK)

Department of Pediatrics and Adolescent Medicine, Josefinum Augsburg, Augsburg, Germany.

F B Fahlbusch (FB)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Loschgestr. 15, 91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH